Marketdash
Back to News

Analyst Price Targets: GE Vernova Could Jump 33% While Homebuilder Takes Downgrade Hit

MarketDash Editorial Team
11 hours ago
Wall Street analysts made notable moves Thursday, with GE Vernova upgraded to Buy and a price target suggesting 33% upside. Meanwhile, Lennar got downgraded as housing concerns mount, and tech darling Micron saw its target raised to $350.

Thursday brought a fresh wave of analyst calls across Wall Street, with some pretty dramatic moves that suggest shifting sentiment in several key sectors. Let's break down what the smart money is thinking.

The Big Upgrade: GE Vernova's Power Play

The headline grabber comes from Jefferies, which upgraded GE Vernova Inc (GEV) from Hold to Buy and bumped its price target from $736 to $815. That new target implies about 33% upside from where the stock closed Tuesday at $614.19. Analyst Julien Dumoulin-Smith apparently sees something compelling in the energy infrastructure play that spun out of General Electric last year.

Tech and Memory Chips Still Hot

Morgan Stanley's Meta Marshall remains bullish on Micron Technology Inc (MU), raising the firm's price target from $338 to $350 while maintaining an Overweight rating. The memory chip maker closed Wednesday at $225.71, which means there's still substantial upside built into that forecast even after the stock's already impressive run.

Housing Market Concerns Hit Lennar

Not everyone got good news Thursday. Bank of America Securities analyst Rafe Jadrosich downgraded Lennar Corp (LEN) from Neutral to Underperform and slashed the price target from $125 to $95. That's a meaningful cut for the homebuilder, which closed Wednesday at $112.23. The downgrade likely reflects concerns about affordability pressures and interest rate impacts on the housing market.

Medical Device Maker Gets Trimmed

Stifel's Jonathan Block cut his price target on Resmed Inc (RMD) from $270 to $260 while maintaining a Hold rating. The sleep apnea device maker closed Wednesday at $245.94, trading a bit below even the reduced target.

Insurance and Consumer Staples Adjustments

In the insurance world, BMO Capital's Michael Zaremski trimmed Progressive Corp (PGR) from $256 to $253 while keeping a Market Perform rating. Progressive shares closed Wednesday at $227.27.

Meanwhile, Bernstein analyst Alexia Howard made a modest adjustment to General Mills Inc (GIS), cutting the price target from $55 to $54 with a Market Perform rating. The cereal and packaged food giant settled at $48.61 Wednesday, suggesting some potential upside even with the lowered target.

Energy Services Getting Love

Piper Sandler's Derek Podhaizer sees significant upside in Weatherford International plc (WFRD), raising the price target from $80 to $95 while maintaining an Overweight rating. The oilfield services company closed Wednesday at $77.40, meaning the analyst sees roughly 23% upside potential.

Smaller Cap Movers

HC Wainwright analyst Raghuram Selvaraju boosted his price target on Climb Bio Inc (CLYM) from $9 to $11, maintaining a Buy rating. The biotech closed Wednesday at $4.25, well below the target, which suggests either massive upside potential or significant execution risk depending on your perspective.

Needham's Tom Nikic increased the price target for VF Corp (VFC) from $19 to $21 while keeping a Buy rating. The apparel company behind brands like Vans and The North Face settled at $18.54 Wednesday.

REIT Gets Double Boost

JP Morgan analyst Michael Mueller upgraded Federal Realty Investment Trust (FRT) from Neutral to Overweight and raised the price target from $107 to $114. The shopping center REIT closed Wednesday at $101.70, suggesting meaningful upside if Mueller's thesis plays out.

These analyst calls offer a snapshot of where Wall Street sees opportunity and risk heading into the new year. Of course, price targets are educated guesses, not guarantees, but they do reflect where experienced analysts think fair value lies based on their models and industry insights.

Back to News

Analyst Price Targets: GE Vernova Could Jump 33% While Homebuilder Takes Downgrade Hit

MarketDash Editorial Team
11 hours ago
Wall Street analysts made notable moves Thursday, with GE Vernova upgraded to Buy and a price target suggesting 33% upside. Meanwhile, Lennar got downgraded as housing concerns mount, and tech darling Micron saw its target raised to $350.

Thursday brought a fresh wave of analyst calls across Wall Street, with some pretty dramatic moves that suggest shifting sentiment in several key sectors. Let's break down what the smart money is thinking.

The Big Upgrade: GE Vernova's Power Play

The headline grabber comes from Jefferies, which upgraded GE Vernova Inc (GEV) from Hold to Buy and bumped its price target from $736 to $815. That new target implies about 33% upside from where the stock closed Tuesday at $614.19. Analyst Julien Dumoulin-Smith apparently sees something compelling in the energy infrastructure play that spun out of General Electric last year.

Tech and Memory Chips Still Hot

Morgan Stanley's Meta Marshall remains bullish on Micron Technology Inc (MU), raising the firm's price target from $338 to $350 while maintaining an Overweight rating. The memory chip maker closed Wednesday at $225.71, which means there's still substantial upside built into that forecast even after the stock's already impressive run.

Housing Market Concerns Hit Lennar

Not everyone got good news Thursday. Bank of America Securities analyst Rafe Jadrosich downgraded Lennar Corp (LEN) from Neutral to Underperform and slashed the price target from $125 to $95. That's a meaningful cut for the homebuilder, which closed Wednesday at $112.23. The downgrade likely reflects concerns about affordability pressures and interest rate impacts on the housing market.

Medical Device Maker Gets Trimmed

Stifel's Jonathan Block cut his price target on Resmed Inc (RMD) from $270 to $260 while maintaining a Hold rating. The sleep apnea device maker closed Wednesday at $245.94, trading a bit below even the reduced target.

Insurance and Consumer Staples Adjustments

In the insurance world, BMO Capital's Michael Zaremski trimmed Progressive Corp (PGR) from $256 to $253 while keeping a Market Perform rating. Progressive shares closed Wednesday at $227.27.

Meanwhile, Bernstein analyst Alexia Howard made a modest adjustment to General Mills Inc (GIS), cutting the price target from $55 to $54 with a Market Perform rating. The cereal and packaged food giant settled at $48.61 Wednesday, suggesting some potential upside even with the lowered target.

Energy Services Getting Love

Piper Sandler's Derek Podhaizer sees significant upside in Weatherford International plc (WFRD), raising the price target from $80 to $95 while maintaining an Overweight rating. The oilfield services company closed Wednesday at $77.40, meaning the analyst sees roughly 23% upside potential.

Smaller Cap Movers

HC Wainwright analyst Raghuram Selvaraju boosted his price target on Climb Bio Inc (CLYM) from $9 to $11, maintaining a Buy rating. The biotech closed Wednesday at $4.25, well below the target, which suggests either massive upside potential or significant execution risk depending on your perspective.

Needham's Tom Nikic increased the price target for VF Corp (VFC) from $19 to $21 while keeping a Buy rating. The apparel company behind brands like Vans and The North Face settled at $18.54 Wednesday.

REIT Gets Double Boost

JP Morgan analyst Michael Mueller upgraded Federal Realty Investment Trust (FRT) from Neutral to Overweight and raised the price target from $107 to $114. The shopping center REIT closed Wednesday at $101.70, suggesting meaningful upside if Mueller's thesis plays out.

These analyst calls offer a snapshot of where Wall Street sees opportunity and risk heading into the new year. Of course, price targets are educated guesses, not guarantees, but they do reflect where experienced analysts think fair value lies based on their models and industry insights.